Off-target effects of psychoactive drugs revealed by genome-wide assays in yeast.
Ontology highlight
ABSTRACT: To better understand off-target effects of widely prescribed psychoactive drugs, we performed a comprehensive series of chemogenomic screens using the budding yeast Saccharomyces cerevisiae as a model system. Because the known human targets of these drugs do not exist in yeast, we could employ the yeast gene deletion collections and parallel fitness profiling to explore potential off-target effects in a genome-wide manner. Among 214 tested, documented psychoactive drugs, we identified 81 compounds that inhibited wild-type yeast growth and were thus selected for genome-wide fitness profiling. Many of these drugs had a propensity to affect multiple cellular functions. The sensitivity profiles of half of the analyzed drugs were enriched for core cellular processes such as secretion, protein f
SUBMITTER: Ericson E
PROVIDER: S-EPMC2483942 | biostudies-literature | 2008 Aug
REPOSITORIES: biostudies-literature
ACCESS DATA